Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

ABSTRACT: We perform RNA-seq on matched orthotopic murine primary and metastatic prostate cancer samples to identify differential gene expressions

ORGANISM(S): Mus musculus

PROVIDER: GSE64771 | GEO | 2015/01/30

SECONDARY ACCESSION(S): PRJNA271869

REPOSITORIES: GEO